Ben-Gal T - Search Results

1

Six-months immunogenicity of BNT162b2 mRNA vaccine in heart transplanted and ventricle assist device-supported patients.

Itzhaki Ben Zadok O, Shaul AA, Ben-Avraham B, Yaari V, Ben Zvi H, Eliakim-Raz N, Yahav D, Abed G, Abuhazira M, Barac YD, Mats I, Shochat T, Aravot D, Kornowski R, Ben-Gal T. Itzhaki Ben Zadok O, et al. ESC Heart Fail. 2022 Apr;9(2):905-911. doi: 10.1002/ehf2.13798. Epub 2022 Jan 3. ESC Heart Fail. 2022. PMID: 34981657 Free PMC article.

2

Etiological factors influencing the development of atrioventricular valve incompetence after heart transplantation.

Sahar G, Stamler A, Erez E, Ben-Gal T, Sagle A, Aravot D, Vidne BA. Sahar G, et al. Transplant Proc. 1997 Sep;29(6):2675-6. doi: 10.1016/s0041-1345(97)00552-6. Transplant Proc. 1997. PMID: 9290786 No abstract available.

3

Importance of the cardiothoracic ratio in the evaluation of cardiac transplant candidates.

Berman M, Erez E, Ben-Gal T, Sahar G, Vidne B, Aravot D. Berman M, et al. Transplant Proc. 1999 Jun;31(4):1885-6. doi: 10.1016/s0041-1345(99)00199-2. Transplant Proc. 1999. PMID: 10371984 No abstract available.

4

Right atrial dilatation: major contributor to increased cardiothoracic ratio in cardiac transplant candidates.

Aravot D, Berman M, Ben-Gal T, Erez E, Sahar G, Mansur M, Vidne B, Sagie A. Aravot D, et al. Transplant Proc. 1999 Jun;31(4):1887-8. doi: 10.1016/s0041-1345(99)00200-6. Transplant Proc. 1999. PMID: 10371985 No abstract available.

5

Employment is a misleading indicator for successful outcome after heart transplantation.

Sahar G, Stamler A, Erez E, Sagie A, Ben-Gal T, Lerman M, Aravot D, Vidne BA. Sahar G, et al. Transplant Proc. 1999 Jun;31(4):1905-6. doi: 10.1016/s0041-1345(99)00149-9. Transplant Proc. 1999. PMID: 10371995 No abstract available.

6

Cardiothoracic ratio: important prognostic tool in heart failure patients who are candidates for heart transplantation.

Berman M, Aravot D, Ben-Gal T, Sahar G, Sagie A, Vidne B. Berman M, et al. Transplant Proc. 2000 Jun;32(4):727-8. doi: 10.1016/s0041-1345(00)00958-1. Transplant Proc. 2000. PMID: 10856560 No abstract available.

7

Role of cyclosporine in inducing hyperuricemia in heart transplant patients.

Sahar G, Stamler A, Berman M, Ben Gal T, Vaturi M, Aravot D, Vidne BA. Sahar G, et al. Transplant Proc. 2000 Jun;32(4):729-30. doi: 10.1016/s0041-1345(00)00959-3. Transplant Proc. 2000. PMID: 10856561 No abstract available.

8

Functional status and quality of life of heart transplant recipients surviving beyond 5 years.

Aravot D, Berman M, Ben-Gal T, Sahar G, Vidne B. Aravot D, et al. Transplant Proc. 2000 Jun;32(4):731-2. doi: 10.1016/s0041-1345(00)00960-x. Transplant Proc. 2000. PMID: 10856562 No abstract available.

9

Natural history of left-sided valves after heart transplantation.

Vaturi M, Aravot D, Ben-Gal T, Shapira Y, Adler Y, Sahar G, Vidne B, Sagie A. Vaturi M, et al. Transplant Proc. 2000 Jun;32(4):735-6. doi: 10.1016/s0041-1345(00)00962-3. Transplant Proc. 2000. PMID: 10856564 No abstract available.

10

Long-term physical training in cardiac transplant candidates: is it feasible?

Ben-Gal T, Pinchas A, Zafrir N, Sahar G, Berman M, Aravot D. Ben-Gal T, et al. Transplant Proc. 2000 Jun;32(4):740-2. doi: 10.1016/s0041-1345(00)00964-7. Transplant Proc. 2000. PMID: 10856566 Clinical Trial. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

183 results

Search Page